CoLabs Int’l
Think On Your Skin, Not Through Your Skin
Overview
Raised: $16,250
Total Commitments ($USD)
Dalmore Group
05/24/2021
Not Provided
$650
Equity - Common
Series A
RegA+
$6.50
$117,812,500
Rolling Commitments ($USD)
05/31/2022
$44
5
2008
Healthcare & Pharmaceuticals
Biotech
B2C
Medium
High
Balance Sheet
|
Cash and Cash Equivalents |
$230,000 |
|
Accounts and Notes Receivable |
$2,000 |
| Total Assets |
$328,000 |
|
Accounts Payable & Accrued Liabilities |
$46,000 |
|
Long Term Debt |
$99,000 |
|
Total Liabilities |
$170,000 |
|
Total Stockholders' Equity |
$158,000 |
| Total Liabilities and Equity |
$328,000 |
Statement of Comprehensive Income Information
|
Total Revenues |
$105,000 |
|
Costs & Expenses Applicable to Rev |
$61,000 |
|
Depreciation and Amortization |
$24,000 |
| Net Income |
$-826,000 |
|
Earnings Per Share - Basic |
$-0.06 |
|
Earnings Per Share - Diluted |
$-0.06 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual